Pharmaclic Assets SA
Pharmaclic Assets reported total assets of €14.0m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
By total assets for 2025, Pharmaclic Assets ranks among the 50 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharmaclic Assets shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaclic Assets's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Mar 2023
Pharmaclic Assets's financial analysis
- Solvency-6.3%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaclic Assets
Pharmaclic Assets's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.869.301
- VAT number
- BE0877869301
- Peppol
- Registered · 0208:0877869301 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 13 Dec 2005
- Registered office
- 1140 Evere
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaclic Assets (SA) has been based in Evere since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 114,983 € and equity of −877,138 €; its revenue is not published. Its solvency stands at -6.3%, below the median of its sector (37.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaclic Assets
Companies in the same business, of comparable size and area, outside its group.
- Devanthinic Pharma Activities of holding companies Seneffe · balance sheet €16.8m
- Healis Holding Activities of holding companies Geel · balance sheet €53.0m
- Decura Pharma Activities of holding companies Ostend · balance sheet €12.0m
- Silesam Activities of holding companies Roeselare · balance sheet €42.5m
- Wim de Marez Activities of holding companies Schaerbeek · balance sheet €8.97m
- VSF Management Business and other management consultancy activities Nandrin · balance sheet €11.3m
- Wisli Invest Activities of holding companies Beernem · balance sheet €28.4m
- Docpharma Manufacture of perfume and toilet preparations Hoeilaart · balance sheet €48.2m
Frequently asked questions about Pharmaclic Assets
What is the revenue of Pharmaclic Assets?
Pharmaclic Assets files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaclic Assets?
In Belgium, the VAT number is the company number prefixed with BE: BE0877869301 for Pharmaclic Assets, if the company is VAT-registered. Its company number (CBE) is 0877.869.301.
Where is the registered office of Pharmaclic Assets?
According to the CBE register, the registered office of Pharmaclic Assets is in 1140 Evere.
What is the equity of Pharmaclic Assets?
At the close of the 2025 financial year, the equity of Pharmaclic Assets amounts to -877,138 €, a solvency of -6.3% of total assets.
Who manages Pharmaclic Assets?
The register lists 2 active mandates at Pharmaclic Assets. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharmaclic Assets within its sector?
By total assets for 2025, Pharmaclic Assets ranks among the 50 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Pharmaclic Assets
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →